HALBERT DAVID D 内部人交易：近期 SEC Form 4 交易
过去 18 个月，HALBERT DAVID D（CIK 1034380）在 1 家公司共报告 6 笔 SEC Form 4 内部人交易（最近一笔 2026-05-18）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-05-18 | Caris Life Sciences, Inc. (CAI) | Founder, Chairman, and Chief Executive Officer | 卖出 | 40,712 | $620,858 |
| 2026-03-10 | Caris Life Sciences, Inc. (CAI) | Founder, Chairman, and Chief Executive Officer | 买入 | 320,112 | $0 |
| 2025-08-13 | Caris Life Sciences, Inc. (CAI) | Founder, Chairman, and Chief Executive Officer | 卖出 | 141,956 | $4.2M |
| 2025-06-23 | Caris Life Sciences, Inc. (CAI) | Founder, Chairman, and Chief Executive Officer; ADAPT I Ltd. and Carisome I, L.P. are filing a separate Form 4 with respect to the transactions reported herein | 买入 | 360,750 | $0 |
| 2025-06-23 | Caris Life Sciences, Inc. (CAI) | Founder, Chairman, and Chief Executive Officer; ADAPT I Ltd. and Carisome I, L.P. are filing a separate Form 4 with respect to the transactions reported herein | 买入 | 413,839 | $0 |
| 2025-06-23 | Caris Life Sciences, Inc. (CAI) | Founder, Chairman, and Chief Executive Officer; ADAPT I Ltd. and Carisome I, L.P. are filing a separate Form 4 with respect to the transactions reported herein | 买入 | 104.8M | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-05-18